COVID-19 and Cancer: New study looks at COVID-19 in individuals at high risk for multiple myeloma

preview_player
Показать описание
Irene Ghobrial, MD, explains the Immune Profiling with Antibody-based COVID-19 Testing (IMPACT) study, which will investigate the short and long-term impact of COVID-19 of a population who is at risk of developing multiple myeloma or who has a precursor condition to myeloma.
Video published 11/13/20
Рекомендации по теме
Комментарии
Автор

My partner got diagnosed with multiple myeloma last week he took the Pfizer vaccine last June. This is frustrating

meganfernandes
Автор

My gram was riddled with cancer after all of her shots. Shes gone now. Im glad she was protected against a 99 percent survival rate virus though

unbalancedlibra
Автор

My ex wife was in remission. Working. Living life again. Clear. Full body pet scans. Clear. Then it went to her brain after she was vaccinated. I asked her not to take it. One of her Drs said dont. But the others told her to. There's 3 other people in my circle in the same boat.

scottpollock
Автор

I'm still clear from ovarian cancer, have been for two years now. Will have to ask my oncology doctor about this

ankicat